Literature DB >> 24926400

Management of diabetic retinopathy.

D Ellis1, P I Burgess2, P Kayange3.   

Abstract

Sub-Saharan Africa faces an epidemic of diabetes. Visual loss from diabetic retinopathy (DR) is both preventable and treatable. This article reviews the epidemiology and clinical features of DR and current evidence-based interventions in three areas: primary prevention of retinopathy by optimum medical management, early detection of pre-symptomatic disease and management of established retinopathy to prevent or mitigate visual loss. There are significant challenges to DR care in resource poor environments. Appropriate provision of effective interventions by health services can reduce social and economic costs associated with patient care.

Entities:  

Mesh:

Year:  2013        PMID: 24926400      PMCID: PMC4052230     

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  33 in total

1.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

2.  Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Authors:  A Keech; R J Simes; P Barter; J Best; R Scott; M R Taskinen; P Forder; A Pillai; T Davis; P Glasziou; P Drury; Y A Kesäniemi; D Sullivan; D Hunt; P Colman; M d'Emden; M Whiting; C Ehnholm; M Laakso
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

3.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

4.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study.

Authors:  S P Harding; D M Broadbent; C Neoh; M C White; J Vora
Journal:  BMJ       Date:  1995-10-28

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

Authors:  E Y Chew; M L Klein; F L Ferris; N A Remaley; R P Murphy; K Chantry; B J Hoogwerf; D Miller
Journal:  Arch Ophthalmol       Date:  1996-09

9.  The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

Review 10.  Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic.

Authors:  Philip I Burgess; Gerald Msukwa; Nicholas A V Beare
Journal:  BMC Med       Date:  2013-07-02       Impact factor: 8.775

View more
  5 in total

1.  QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY REVEALS ROD PHOTORECEPTOR DEGENERATION in EARLY DIABETIC RETINOPATHY.

Authors:  David Le; Taeyoon Son; Jennifer I Lim; Xincheng Yao
Journal:  Retina       Date:  2022-08-01       Impact factor: 3.975

2.  Visual impairment and blindness in type 2 diabetics: Ife-Ijesa diabetic retinopathy study.

Authors:  O H Onakpoya; B A Kolawole; A O Adeoye; B O Adegbehingbe; O Laoye
Journal:  Int Ophthalmol       Date:  2015-11-04       Impact factor: 2.031

3.  Assessment of circulating fibrotic proteins (periostin and tenascin -C) In Type 2 diabetes mellitus patients with and without retinopathy.

Authors:  A Indumathi; Gandhipuram Periyaswamy Senthilkumar; Kuppuswamy Jayashree; K Ramesh Babu
Journal:  Endocrine       Date:  2022-03-10       Impact factor: 3.925

4.  Use of Smartphones to Detect Diabetic Retinopathy: Scoping Review and Meta-Analysis of Diagnostic Test Accuracy Studies.

Authors:  Choon Han Tan; Bhone Myint Kyaw; Helen Smith; Colin S Tan; Lorainne Tudor Car
Journal:  J Med Internet Res       Date:  2020-05-15       Impact factor: 5.428

5.  Use of smartphones for detecting diabetic retinopathy: a protocol for a scoping review of diagnostic test accuracy studies.

Authors:  Choon Han Tan; Willie-Henri Quah; Colin S H Tan; Helen Smith; Lorainne Tudor Car
Journal:  BMJ Open       Date:  2019-12-08       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.